Pacira BioSciences' Total Liabilities fell 26.13% to $570.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $570.4 million, marking a year-over-year decrease of 26.13%. This contributed to the annual value of $775.2 million for FY2024, which is 10.07% up from last year.
Pacira BioSciences' Total Liabilities amounted to $570.4 million in Q3 2025, which was down 26.83% from $779.5 million recorded in Q2 2025.
Pacira BioSciences' Total Liabilities' 5-year high stood at $1.3 billion during Q4 2021, with a 5-year trough of $570.4 million in Q3 2025.
Over the past 3 years, Pacira BioSciences' median Total Liabilities value was $755.4 million (recorded in 2023), while the average stood at $731.0 million.
In the last 5 years, Pacira BioSciences' Total Liabilities skyrocketed by 105.39% in 2021 and then tumbled by 36.09% in 2023.
Pacira BioSciences' Total Liabilities (Quarterly) stood at $1.3 billion in 2021, then crashed by 32.62% to $906.2 million in 2022, then declined by 22.28% to $704.3 million in 2023, then climbed by 10.07% to $775.2 million in 2024, then fell by 26.13% to $570.4 million in 2025.
Its last three reported values are $570.4 million in Q3 2025, $779.5 million for Q2 2025, and $788.1 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value